课题基金 / 基金详情

Multiplexed proteomics-based kinase assay development

Multiplexed proteomics-based kinase assay development
基于多重蛋白质组学的激酶测定开发
批准号:
10793244
负责人:
Laurie L. Parker
金额:
$11.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2026-04-30

项目摘要

项目成果

Laurie L. Parker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary This supplement application is to request a MultiPep2 peptide library synthesizer from CEM Corporation, to be used for preparing libraries of synthetic peptide candidates as a critical part of our efforts in optimal kinase substrate peptide design. The major, overarching goal of this R01 project is to develop panels of cell-deliverable peptide substrates for kinases that will enable identification of signatures of signaling activity in live cells using high-throughput targeted mass spectrometry. There are two components of this development in progress: · Kinase substrate preference mapping, and peptide substrate design based on those preferences · Focused selection of substrates that perform well in mass spectrometry detection Both of these goals require screening of many peptides to determine the best candidates to define a given kinase's activity, which we will eventually establish as assays using the targeted mass spectrometry approaches that are in development with our collaborator at Cedars Sinai. The MultiPep2 instrument is a library-scale peptide synthesizer, with versatile capabilities to synthesize up to 384 peptides per run, at a small multiwell- plate scale that is far more resource and reagent-efficient for this purpose than our current production-scale, non-library synthesizer, which can only make up to 24 at a time at about 10X greater scale and thus reagent and solvent usage. This will enhance the project's efficiency in screening peptide candidates, reduce solvent usage, associated reagent costs, and environmental impact, and reduce researcher time on library synthesis, reserving it for more intellectually demanding aspects of the work.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplexed proteomics-based kinase assay development
  • 批准号:
    10810004
  • 项目类别:
  • 资助金额:
    $1.01万
  • 财政年份:
    2022
  • 负责人:
    Laurie L. Parker
  • 依托单位:
Multiplexed proteomics-based kinase assay development
  • 批准号:
    10467462
  • 项目类别:
  • 资助金额:
    $32.76万
  • 财政年份:
    2022
  • 负责人:
    Laurie L. Parker
  • 依托单位:
Multiplexed proteomics-based kinase assay development
  • 批准号:
    10615893
  • 项目类别:
  • 资助金额:
    $31.38万
  • 财政年份:
    2022
  • 负责人:
    Laurie L. Parker
  • 依托单位:
High-Throughput Screening Platform for Cancer Drug Discovery
  • 批准号:
    10432025
  • 项目类别:
  • 资助金额:
    $70.38万
  • 财政年份:
    2020
  • 负责人:
    Laurie L. Parker
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: